Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

Summary

The purpose of this study in healthy adult males is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The purpose of this study in patients with Parkinson's disease is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The exploratory efficacy of KDT-3594 will also be investigated.

Timeline

Start

2017-02-20

Primary completion

2018-08-13

Completion

2018-08-13

Drugs

Indications